The hypocretin neurotransmission system in myotonic dystrophy type 1

Neurology
E CiafaloniC A Thornton

Abstract

Patients with myotonic dystrophy type 1 (DM1) frequently have symptoms of excessive daytime sleepiness (EDS). Some patients with DM1 show sleep-onset REM, similar to that observed in narcolepsy. Narcolepsy is characterized by impaired hypocretin (Hcrt) neurotransmission. To test for dysregulation of Hcrt neurotransmission in a prospective cohort of patients with DM1. Hcrt levels in CSF were measured by radioimmunoassay. Sleep physiology was assessed by overnight polysomnography (PSG) and a multiple sleep latency test (MSLT). Splicing of Hcrt receptor 1 and 2 (HcrtR1 and HcrtR2) mRNA was examined in postmortem samples of temporal cortex. Seventeen of 38 patients with DM1 reported symptoms of EDS. Among patients with DM1 with EDS who underwent PSG/MSLT, 7 of 13 showed reduced sleep latency, sleep-onset REM, or both. However, CSF Hcrt levels in DM1 (mean 277 pg/mL, n = 38) were not different from controls (mean 277 pg/mL, n = 33). Also, splicing of HcrtR1 and HcrtR2 mRNA in patients with DM1 was similar to controls. Excessive daytime sleepiness and dysregulation of REM sleep occur frequently in patients with myotonic dystrophy type 1 (DM1). However, the pathophysiologic basis is distinct from narcolepsy, as patients with DM1 do no...Continue Reading

Citations

Feb 19, 2009·Journal of Neurology·Martina MinneropCornelia Kornblum
Feb 23, 2013·Current Neurology and Neuroscience Reports·Luc LabergeYves Dauvilliers
Sep 16, 2010·Current Treatment Options in Neurology·Allison Conravey, Lenay Santana-Gould
Dec 2, 2011·Brain : a Journal of Neurology·Martina MinneropCornelia Kornblum
Feb 23, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A RomigiR Massa
Dec 7, 2013·Sleep & Breathing = Schlaf & Atmung·Maria Laura Ester BianchiGabriella Silvestri
Aug 27, 2014·Clinics in Chest Medicine·Christine H J Won, Meir Kryger
Jul 10, 2013·Semergen·L Dominguez-OrtegaUNKNOWN Civil Guard's collaboration
Oct 27, 2012·Neurologic Clinics·Sushanth BhatSudhansu Chokroverty
Jun 2, 2012·Experimental Cell Research·Yang Guo, Pingfu Feng
Apr 3, 2012·Sleep Medicine Reviews·Yves A Dauvilliers, Luc Laberge
Dec 6, 2011·Neuromuscular Disorders : NMD·Alessandro PincherleLucia Morandi
May 1, 2009·Neuromuscular Disorders : NMD·Luc LabergeJean Mathieu
Sep 30, 2008·Sleep Medicine Reviews·Rolf FronczekSebastiaan Overeem
Jun 17, 2008·Seminars in Pediatric Neurology·Sanjeev V Kothare, Joseph Kaleyias
Feb 13, 2015·Rinshō shinkeigaku = Clinical neurology·Mitsuru Kawai
Jun 2, 2009·Journal of the American Geriatrics Society·Harrison G BloomPhyllis C Zee
Nov 12, 2014·Journal of Neurology·Christos KrogiasChristiane Schneider-Gold
Jun 15, 2015·Seminars in Pediatric Neurology·Thomas J DyeSanjeev V Kothare
Dec 7, 2016·Continuum : Lifelong Learning in Neurology·Valeria A Sansone
Jun 18, 2017·Respirology : Official Journal of the Asian Pacific Society of Respirology·Matthias Boentert
Feb 11, 2019·Current Neurology and Neuroscience Reports·Andrea RomigiAlessandro Sanduzzi
Jan 1, 2013·Journal of Neurodegenerative Diseases·A RomigiR Massa
Nov 2, 2018·Current Neurology and Neuroscience Reports·Andrea RomigiRoberto Massa
Feb 18, 2017·Neurologia i neurochirurgia polska·Katarzyna Kapica-TopczewskaAlina Kułakowska
Mar 3, 2020·Frontiers in Neurology·Yuka UrataAkira Sano
Mar 27, 2020·Muscle & Nerve·Sub H SubramonyEric T Wang
Jul 11, 2021·Neuromuscular Disorders : NMD·Stojan PericGiovanni Meola

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.